检验医学 ›› 2024, Vol. 39 ›› Issue (5): 429-437.DOI: 10.3969/j.issn.1673-8640.2024.05.003

• 论著 • 上一篇    下一篇

宫颈癌患者lncRNA HAND2-AS1表达及其对宫颈癌Caski细胞增殖、侵袭和迁移能力的影响

张晓科1, 褚艳荣2, 王荣3, 崔发财3()   

  1. 1.焦作市妇幼保健院检验科,河南 焦作 454000
    2.焦作市妇幼保健院妇产科,河南 焦作 454000
    3.河南省人民医院 郑州大学人民医院检验科,河南 郑州 450003
  • 收稿日期:2023-03-04 修回日期:2023-11-18 出版日期:2024-05-30 发布日期:2024-06-12
  • 通讯作者: 崔发财,E-mail:cuifacail@163.com
  • 作者简介:张晓科,男,1983年生,学士,主管技师,主要从事临床免疫学和临床微生物学检验工作。
  • 基金资助:
    国家自然科学基金项目(82002210)

Serum lncRNA HAND2-AS1 expression in cervical cancer patients and its effect on proliferation,invasion and migration of cervical cancer Caski cells

ZHANG Xiaoke1, CHU Yanrong2, WANG Rong3, CUI Facai3()   

  1. 1. Department of Clinical Laboratory,Jiaozuo Maternal and Child Health Care Hospital, Jiaozuo 454000, Henan,China
    2. Department of Obstetrics and Gynecology, Jiaozuo Maternal and Child Health Care Hospital,Jiaozuo 454000,Henan,China
    3. Department of Clinical Laboratory,Henan Provincial People's Hospital,the People's Hospital of Zhengzhou University, Zhengzhou 450003,Henan,China
  • Received:2023-03-04 Revised:2023-11-18 Online:2024-05-30 Published:2024-06-12

摘要:

目的 探讨宫颈癌患者血清长链非编码RNA(lncRNA)心脏和神经嵴衍生物表达转录本2反义序列1(HAND2-AS1)表达的临床意义,分析lncRNA HAND2-AS1对宫颈癌Caski细胞增殖、侵袭和迁移的影响机制。方法 采用基因表达交互分析(GEPIA)数据库分析lncRNA HAND2-AS1在宫颈癌组织和正常宫颈组织中的表达情况。选取2019年1月—2021年12月焦作市妇幼保健院宫颈癌患者48例(宫颈癌组)、宫颈上皮内瘤变(CIN)患者48例(CIN组)和健康体检者48名(正常对照组)。收集其中14例宫颈癌患者术后癌组织和癌旁组织(距癌组织边缘>2 cm)样本,同时收集所有研究对象血清样本和临床资料,检测lncRNA HAND2-AS1相对表达量。将宫颈癌细胞系Caski按转染质粒的不同分为过表达组(转染pcDNA3.1-HAND2-AS1)和阴性对照组(转染pcDNA3.1-NC)、干扰组(转染si-HAND2-AS1)和干扰对照组(转染si-NC)。采用CCK-8实验、Transwell实验和划痕实验检测细胞的增殖、侵袭和迁移能力,采用免疫印迹法检测细胞内磷脂酰肌醇3-激酶(PI3K)、磷酸化磷脂酰肌醇3-激酶(p-PI3K)、蛋白激酶B(Akt)和磷酸化蛋白激酶B(p-Akt)的表达情况。结果 GEPIA数据库分析结果显示,宫颈癌组织lncRNA HAND2-AS1表达显著低于正常宫颈上皮组织(P<0.05)。14例宫颈癌患者癌组织lncRNA HAND2-AS1相对表达量显著低于癌旁组织(P=0.001)。宫颈癌组血清lncRNA HAND2-AS1相对表达量显著低于CIN组和正常对照组(P<0.001),CIN组与正常对照组之间差异无统计学意义(P>0.05)。不同肿瘤大小、国际妇产科学联合会(FIGO)分期和有无淋巴转移的宫颈癌患者之间血清lncRNA HAND2-AS1相对表达量差异均有统计学意义(P<0.05)。过表达组lncRNA HAND2-AS1相对表达量显著高于阴性对照组(P<0.01),细胞增殖活性、侵袭细胞数、划痕愈合率和p-PI3K、p-Akt蛋白相对表达量均低于阴性对照组(P<0.05)。干扰组lncRNA HAND2-AS1相对表达量显著低于干扰对照组(P<0.001),细胞增殖活性、侵袭细胞数、划痕愈合率和p-PI3K、p-Akt蛋白相对表达量均显著高于干扰对照组(P<0.05)。过表达组与阴性对照组之间、干扰组与干扰对照组之间PI3K和Akt蛋白相对表达量差异均无统计学意义(P>0.05)。结论 宫颈癌患者血清lncRNA HAND2-AS1呈低表达,且与病情严重程度有关。lncRNA HAND2-AS1可能通过调控PI3K/Akt信号通路影响宫颈癌细胞的增殖、侵袭和迁移。

关键词: 心脏和神经嵴衍生物表达转录本2反义序列1, 长链非编码RNA, 宫颈癌, 侵袭, 迁移

Abstract:

Objective To investigate the expression of long non-coding RNA(lncRNA)heart and neural crest derivatives expressed 2-antisense RNA 1(HAND2-AS1)in serum of cervical cancer patients and the mechanism of its effect on the proliferation,invasion and migration of cervical cancer Caski cells. Methods The Gene Expression Profiling Interactive Analysis(GEPIA) database was used to analyze the expression of lncRNA HAND2-AS1 in cervical cancer tissues and normal cervical tissues. From January 2019 to December 2021,48 patients with cervical cancer(cervical cancer group),48 patients with cervical intraepithelial neoplasia(CIN)(CIN group) and 48 healthy subjects(healthy control group) were enrolled from Jiaozuo Maternal and Child Health Care Hospital. The samples of postoperative cancer tissue and adjacent tissue(>2 cm from the margin of cancer tissue) were collected from 14 patients with cervical cancer. Serum samples and clinical data of all the subjects were collected to determine the relative expression level of lncRNA HAND2-AS1. Cervical cancer cell line Caski was classified into overexpression group(transfected with pcDNA3.1-HAND2-AS1),negative control group(transfected with pcDNA3.1-NC),interference group(transfected with si-HAND2-AS1) and interference control group(transfected with si-NC) according to different transfected plasmids. The proliferation,invasion and migration were determined by CCK-8 assay,Transwell assay and scratch test. The expressions of phosphatidylinositol 3-kinase(PI3K),phosphorylated phosphatidylinositol 3-kinase(p-PI3K),protein kinase B(Akt) and phosphorylated protein kinase B(p-Akt) were determined by western blot. Results The lncRNA HAND2-AS1 expression in cervical cancer tissues was lower than that in normal cervical epithelial tissues(P<0.05). The relative expression level of lncRNA HAND2-AS1 in cancer tissues of 14 patients with cervical cancer was lower than that in adjacent tissues(P<0.01). The relative expression level of serum lncRNA HAND2-AS1 in cervical cancer group was lower than those in CIN group and healthy control group(P<0.01),but there was no statistical significance between CIN group and healthy control group(P>0.05). The relative expression level of serum lncRNA HAND2-AS1 had statistical significance among cervical cancer patients with different tumor sizes,the International Federation of Gynecology and Obstetrics(FIGO) stages and lymphatic metastasis(P<0.05). The relative expression level of lncRNA HAND2-AS1 in overexpression group was higher than that in negative control group(P<0.01),while the cell proliferation activity,the number of invasive cells,scratch healing rate and the relative expression levels of p-PI3K and p-Akt protein in overexpression group were lower than those in negative control group(P<0.05). The relative expression level of lncRNA HAND2-AS1 in interference group was lower than that in interference control group(P<0.01),and the cell proliferation activity,the number of invasive cells,scratch healing rate and the relative expression levels of p-PI3K and p-Akt protein in interference group were higher than those in interference control group(P<0.05). There was no statistical significance in the relative expression levels of PI3K and Akt between overexpression group and negative control group,or between interference group and interference control group(P>0.05). Conclusions Serum lncRNA HAND2-AS1 expression is low in patients with cervical cancer,and it is related to disease severity. The lncRNA HAND2-AS1 may affect the proliferation,invasion and migration of cervical cancer cells by regulating the PI3K/Akt signaling pathway.

Key words: Heart and neural crest derivatives expressed 2-antisense RNA 1, Long non-coding RNA, Cervical cancer, Invasion, Migration

中图分类号: